Patent details

92824 Product Name: ceritinib ou un sel pharmaceutiquement acceptable de celui-ci

Basic Information

Publication number:
92824
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP019059906
Legal Status:
Active
Application number:
92824
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/999
Marketing Authorization Type:
Marketing Authorization Date:
08/05/2015
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
10/09/2015
First Marketing Authorization date:
08/05/2015
Grant date:
24/11/2015
Activation date:
26/02/2021
Publication date:
24/11/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
26/02/2026
SPC Extension Expiration:
26/02/2026
Rejection date:
Withdrawal date:

Owner

From:
10/09/2015
 
 

Name:
ASTRAZENECA AB
Address:
VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
10/09/2015
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
BREAULT Gloria, Anne
Address:
United States (US)

2

Name:
MORRIS Jeffrey, James
Address:
United Kingdom (GB)

3

Name:
PEASE Elizabeth Janet
Address:
United Kingdom (GB)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/01/2025
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages